EUVIMEDEUVIMED entdecken
Crossref

Chemotherapy combined targeted therapy has a potential benefit on the survival of advanced intrahepatic cholangiocarcinoma

Jian Yang, Tengqian Tang, Rui Liao, Yan He, Hua Zhang

Drug Discoveries & Therapeutics · 30.04.2026 · 20 (2) · 155-164

DOI: 10.5582/ddt.2026.01007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 30.04.2026. Verfasst von Jian Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Nanchuan Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Chemoembolization, Therapeutic, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsChemoembolization, TherapeuticAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleRetrospective StudiesMiddle AgedAgedMolecular Targeted TherapyTreatment OutcomeProgression-Free SurvivalPrognosis

Stichwörter der Autor:innen

immunotherapyintrahepatic cholangiocarcinomaliver malignant tumorlocal chemotherapysystemic chemotherapytargeted therapytransarterial chemoembolization

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Nanchuan Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Hepatobiliary Surgery, the First Affiliated Hospital of Army Medical University, Chongqing, China.
  • Sichuan College of Traditional Chinese Medicine, Mianyang, China.

Zitieren

APA

Yang, J., Tang, T., Liao, R., He, Y., & Zhang, H. (2026). Chemotherapy combined targeted therapy has a potential benefit on the survival of advanced intrahepatic cholangiocarcinoma. Drug Discoveries & Therapeutics, 20(2), 155-164. https://doi.org/10.5582/ddt.2026.01007

Vancouver

Yang J, Tang T, Liao R, He Y, Zhang H. Chemotherapy combined targeted therapy has a potential benefit on the survival of advanced intrahepatic cholangiocarcinoma. Drug Discoveries & Therapeutics. 2026;20(2):155-164. doi:10.5582/ddt.2026.01007

BibTeX
@article{Yang2026,
  author = {Yang, Jian and Tang, Tengqian and Liao, Rui and He, Yan and Zhang, Hua},
  title = {Chemotherapy combined targeted therapy has a potential benefit on the survival of advanced intrahepatic cholangiocarcinoma},
  journal = {Drug Discoveries & Therapeutics},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {155--164},
  doi = {10.5582/ddt.2026.01007}
}
Kostenlos starten →